{"a":[{"_":"After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer","$":{"href":"/medtech/after-rejection-fda-approves-telixs-pixclara-first-fet-pet-imaging-drug-brain-cancer","hreflang":"en"}}]}
RegulatoryapprovedPixclaraPositive
AI Analysis
Summary
The FDA approved Telix's Pixclara as the first FET-PET imaging drug for glioma diagnosis, more than a year after its initial rejection.
Outcome Details
FDA approval for Pixclara, first FET-PET imaging drug for brain cancer/glioma
Importance:8/10
Sentiment:
0.85
FDA approvalimaging diagnosticgliomabrain cancerfirst-in-class
Related Companies
Read the original article
Published by FierceBiotech on September 15, 2026 4:27 AM